4//SEC Filing
SENATOR RON 4
Accession 0001178913-11-000895
CIK 0001385830other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 12:05 PM ET
Size
14.7 KB
Accession
0001178913-11-000895
Insider Transaction Report
Form 4
NeurogesX IncNGSX
MOR ISRAEL
Other
Transactions
- Sale
Common Stock
2011-03-24$4.02/sh−120,000$482,940→ 522,046 total(indirect: By Sphera Global Healthcare Master Fund) - Sale
Common Stock
2011-03-24$4.07/sh−32,600$132,610→ 642,046 total(indirect: By Sphera Global Healthcare Master Fund)
SENATOR RON
Other
Transactions
- Sale
Common Stock
2011-03-24$4.07/sh−32,600$132,610→ 642,046 total(indirect: By Sphera Global Healthcare Master Fund) - Sale
Common Stock
2011-03-24$4.02/sh−120,000$482,940→ 522,046 total(indirect: By Sphera Global Healthcare Master Fund)
Transactions
- Sale
Common Stock
2011-03-24$4.02/sh−120,000$482,940→ 522,046 total(indirect: By Sphera Global Healthcare Master Fund) - Sale
Common Stock
2011-03-24$4.07/sh−32,600$132,610→ 642,046 total(indirect: By Sphera Global Healthcare Master Fund)
BREEN DORON
Other
Transactions
- Sale
Common Stock
2011-03-24$4.07/sh−32,600$132,610→ 642,046 total(indirect: By Sphera Global Healthcare Master Fund) - Sale
Common Stock
2011-03-24$4.02/sh−120,000$482,940→ 522,046 total(indirect: By Sphera Global Healthcare Master Fund)
Footnotes (3)
- [F1]These securities are beneficially owned by Sphera Global Healthcare Fund, which invests substantially all of its assets in Sphera Global Healthcare Master Fund. Sphera Global Healthcare Fund and Sphera Global Healthcare Master Fund have delegated all investment decision-making to Sphera Global Healthcare Management L.P. (the "Management Company"). The Management Company is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd. (the "General Partner"), the shares of which are owned 50% by M. Arkin (1999) Ltd. (the "1999 Company") and 50% by Sphera Funds Management Ltd. ("SFML").
- [F2]The 1999 Company, wholly-owned by Moshe Arkin, and SFML are each entitled to appoint two members to the board of directors of the General Partner (the "Board of Directors") and two members to the investment committee of the Management Company (the "Investment Committee"). No decision can be made by either the Board of Directors or the Investment Committee without the consent of both Mr. Arkin's designees and the designees of SFML (Sphera Global Healthcare Fund, Sphera Global Healthcare Master Fund, the Management Company, and the General Partner are referred to collectively in this Form 3 as "Healthcare Fund Entities"). In addition, 62.08% of the shares of SFML are owned by companies controlled or wholly-owned by the three founders of SFML, Israel Mor, Doron Breen, and Ron Senator, each of whom currently serves as a director of SFML.
- [F3]The filing of this Form 4 shall not be construed as an admission that SFML, Mr. Breen, Mr. Mor, or Mr. Senator is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the shares of Common Stock of the Company owned by the Healthcare Fund Entities. Pursuant to Rule 16a-1, SFML, Mr. Breen, Mr. Mor, and Mr. Senator disclaims beneficial ownership of the shares of the Company reported herein that are beneficially owned by the Healthcare Fund Entities, except to the extent of their pecuniary interest therein.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Entity typeother
Related Parties
1- filerCIK 0001496202
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 12:05 PM ET
- Size
- 14.7 KB